Free Webinar: Reopening Your Herbal Products Business -- COVID-19 & the “New Normal”

Market Alerts

July 2022

June 2022

May 2022

April 2022

February 2022

November 2021

  • SCNM Dedicates Ric Scalzo Institute of Botanical Research
  • August 2021

    July 2021

    March 2021

    February 2021

    November 2020

    October 2020

    September 2020

    August 2020

    July 2020

    June 2020

    April 2020

    February 2020

    January 2020

  • Sabinsa's parent company Sami Labs breaks ground on $30 million state of the art production facility
  • Unstoppable Moms Across America launches new Gold Standard to shift the marketplace for a healthier planet
  • Draco Achieves Safe Quality Food (SQF) certification of its manufacturing facilities
  • August 2019

    June 2019

    May 2019

    March 2019

    February 2019

    January 2019

    December 2018

    November 2018

    October 2018

    September 2018

    August 2018

    July 2018

    May 2018

    April 2018

    March 2018

    February 2018

    January 2018

    December 2017

    November 2017

    October 2017

    September 2017

    August 2017

    July 2017

    June 2017

    Free Webinar: Reopening Your Herbal Products Business -- COVID-19 & the “New Normal”

    Presented June 10, 2020

    Published: Wednesday, June 10, 2020

    This free webinar provides practical information on how best to resume post-quarantine business operations while protecting your workforce. Learn what personal protective equipment and workspace adaptations should be implemented and how to manage ongoing business risks and liabilities. Additionally, hear from experts about how to be proactive and search for, and then correct, workplace conditions that could increase risk of COVID-19 infections.

    Overview

    The COVID-19 pandemic caused by the novel coronavirus is likely the most significant public health emergency we have ever faced, both individually and as the health-promoting herbal products industry. As more states and localities across the country announce plans to re-open, businesses must face the question of how to do so as safely, efficiently, and responsibly as possible. What exactly does this new way of conducting business look like for your company? Should your business take a staggered approach to bringing employees back into the workplace based on individual employee factors? Should management require or at least permit remote working indefinitely, or will split-shifts adequately allow employees to maintain social distancing? With safety being a primary factor, what measures are employers implementing to ensure employees are returning to a safe workplace environment?

    With the U.S. Food & Drug Administration (FDA) temporarily postponing all routine surveillance inspections of domestic and foreign facilities due to ongoing concerns about the pandemic, how has the Agency been able to maintain oversight over domestic and foreign manufacturers and imported products using alternative tools and methods? In the short term, FDA has focused instead on only “mission critical” domestic inspections (e.g., those related to a recall or a foodborne illness outbreak). What is FDA’s timeline to resume these inspections?

    Topics

    • Have you updated your employee handbook, policies and/or procedures as a result of COVID-19?
    • Do you have a game plan in place for when an employee blatantly disregards posted safety rules?

    Presenters

      Sean Murray
    President
    Eurofins

    Paul Konney

    Executive Vice President, General Counsel and Head of Global Regulatory Affairs

    Metagenics, Inc.


    Jen Johansen

    Vice President of Quality, Regulatory & Government Affairs

    Cyanotech

    Will Woodlee, Esq.

    Partner

    Kleinfeld, Kaplan and Becker, LLP

    AHPA General Counsel

    Materials/Handouts

    • Presenter slides 
    • Webinar recording

    Cost

    • FREE
    Print

    More links

    2022 Annual Fund Sponsors

    AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.